Left Menu
Development News Edition

COVID-19 treatment: Dr Reddy's partners with Fujifilm, GRA for favipiravir

The company would have exclusive rights for development, selling and distribution of Avigan in India. Further, Fujifilm would receive an upfront undisclosed license fee and royalties on sales from Dr Reddy's and GRA, it said.

PTI | Hyderabad | Updated: 01-07-2020 13:36 IST | Created: 01-07-2020 13:36 IST
COVID-19 treatment: Dr Reddy's partners with Fujifilm, GRA for favipiravir

Dr Reddy's Laboratories on Wednesday announced partnership with Tokyo-based Fujifilm Corporation and Dubai-based Global Response Aid for the development, manufacture and sales of Avigan Tablets (favipiravir), a potential treatment of COVID-19. Under the tripartite agreement, Fujifilm grants Dr Reddy's the exclusive rights of manufacturing.

Also it grants both Dr Reddy's and GRA the rights to develop, sell and distribute Avigan in all countries other than Japan, China and Russia, a press release from the Indian drug maker said. The company would have exclusive rights for development, selling and distribution of Avigan in India.

Further, Fujifilm would receive an upfront undisclosed license fee and royalties on sales from Dr Reddy's and GRA, it said. Fujifilm will provide Dr Reddy's and GRA an array of data on Avigan's preclinical and clinical studies that it has accumulated so far whilethe latterwill use it for clinical studies targeting COVID-19 in regions where infection has been spreading.

In addition, Fujifilmwill grant Dr Reddy's right to use Avigan's patents of formulation and manufacturing method. Dr Reddy's will herewith establish a setup for manufacturing drugs of the same quality as Avigan, and utilize GRA's global sales network to supply the manufactured drugs swiftly and in a stable manner.

The Fujifilm Group is currently conducting a clinical study on Avigan targeting COVID-19 patients in Japan and the US, and is working to increase the drug's production by partnering with domestic and overseas companies. Dr Reddy's and GRA shall introduce the product in the market post all applicable approvals in the respective countries, it added.


TRENDING

OPINION / BLOG / INTERVIEW

Why COVID-19 is unstoppable in USA despite it being ranked at the top of GHS Index?

Several worst-hit countries such as Italy, France, Spain, the UK, Canada, and Russia have peaked COVID-19 cases in April. Almost all of them have gradually flattened the curve. However, the USA is setting new daily records of infections tha...

COVID-19 seems cooking biggest ever global scam

The increasing number of corruption cases on COVID-19 funds from throughout the world and involvement of high profile persons indicate that the countries cant ignore corruption in their pandemic response programs. This has generated the nee...

Health Management Information Systems lack holistic, integrated, and pandemic resilient character

Being a part of the United Nations system, the World Health Organization WHO deserves its share of rebuke for its alleged failure issue COVID-19 health emergency alerts on appropriate time. However, the pandemic has also exposed loopholes i...

Pride in the time of coronavirus: a welcome move online?

This year is different in many ways not least as celebrations are also taking place against the dramatic backdrop of a global health crisis and a resurgence in grassroots activism following the death of George Floyd in Minneapolis. ...

Videos

Latest News

2 key accused in gold smuggling case brought to Kerala

The two key accused in the gold smuggling case in Kerala, Swapna Suresh and Sandeep Nair, were brought to the state on Sunday, a day after being taken into custody by the NIA in Bengaluru, as Congress workers staged protests against them at...

Singapore recorded 178 new COVID-19 cases

Singapores COVID-19 cases reached 45,961 on Sunday after 178 new infections, comprising mostly migrant workers living in dormitories, were detected, according to the health ministry. Among the new infections, 177 are migrant workers living ...

Policybazaar looks to return to profitability this fiscal

Insurance aggregator Policybazaar expects to return to profitability this fiscal on the back of a surge in demand for insurance products amid the COVID-19 pandemic. Growth over the last year is between 70 per cent and 100 per cent dependi...

16 at Raj Bhavan test positive; Guv says not in self-isolation

Sixteen personnel at the Raj Bhavan in south Mumbai have tested coronavirus positive, a civic official said on Sunday. Maharashtra Governor Bhagat Singh Koshyari denied reports that he is in self-isolation, a Raj Bhavan official said.I am p...

Give Feedback